Tolmar recalls

3 official recalls and safety alerts involving Tolmar since 2021-12, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Tolmar or the relevant agency.

  1. 2023-10-04
  2. US
    Drugs & medicalClass III

    Tolmar, Inc. recalls Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC…

    Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

    FDA · DrugTolmar, Inc.Nationwide in the US.Official notice →
  3. 2022-08-10
  4. US
    Drugs & medicalClass II

    Tolmar, Inc. recalls Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tube (NDC 0115-1510-48), b) Net Wt. 40g tube (NDC…

    Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time

    FDA · DrugTolmar, Inc.distributed to 1 consignee in KY.Official notice →
  5. 2021-12-22
  6. US